Dexrazoxane
A cardioprotective agent and bisdioxopiperazine prodrug that is hydrolyzed to an EDTA-like compound that chelates intracellular iron, reducing anthracycline-induced cardiac toxicity in cancer patients receiving high cumulative doxorubicin doses. It is also used to treat extravasation injury from anthracycline chemotherapy.
分子量
268.2700 g/mol
LogP
-1.40
TPSA
98.80 Ų
Lipinski 五规则
符合
治疗领域
作用机制
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
二维结构
Cite this structure
Embed this structure
SMILES
C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1
InChI
InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1
Molecular Formula
C11H16N4O4
HBD / HBA
2 / 6
可旋转键数
3
重原子数
19
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
常见问题
A cardioprotective agent and bisdioxopiperazine prodrug that is hydrolyzed to an EDTA-like compound that chelates intracellular iron, reducing anthracycline-induced cardiac toxicity in cancer patients receiving high cumulative doxorubicin doses. It is also used to treat extravasation injury from anthracycline chemotherapy.
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Yes, Dexrazoxane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1738. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 71384. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="dexrazoxane"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/dexrazoxane/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/dexrazoxane/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/dexrazoxane/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="dexrazoxane"></drugfyi-drug>